Pedifen suspension

Form: Suspension
Dosage: 100ml
Packaging: Oral suspension of 100 ml

Active substance: ibuprofen

Form: pediatric suspension

Dosage: Each ml of Pedifen pediatric suspension contains 20 mg of ibuprofen

Packaging: Bottle of 100 ml

Target: children from 6 months to 12 years

Pedifen pediatric suspension is medicine for children.

Short-term symptomatic treatment in case of:

– mild to moderate pain,

– fever

– Treatment of analgesic and anti-inflammatory symptoms in juvenile arthritis.


  • Pediatric population from 6 months of age
  • The dose of Pedifen Pediatric Suspension depends on age or body weight.
  • The recommended dosage is 10 mg/kg, 3 to 4 times a day, corresponding to a daily dose of 20-30 mg/kg.

Easy calculation: The weight of the child corresponds to the number of ml to be divided into 2 or 3 doses per day

For the treatment of pain and fever, it is recommended not to exceed a total daily dose of 30 mg/kg/day.


If the maximum unit dose is taken, wait at least 6 hours before taking the next dose.


Over-the-counter drug

Notice of Trademark Infringement

Dear valued partners, customers and Dafra representatives,

It has come to our attention that unauthorized use of our company’s name and logo has been observed in various contexts in the African country Togo ( In order to avoid misunderstandings, ever misleading, we feel it is imperative to address this issue promptly and transparently.

Trademark infringement poses a significant threat not only to our brand integrity but also to the trust and credibility we have worked diligently to establish within our community. Our name and logo represent our values, quality, and commitment to excellence, and any unauthorized use undermines these principles.

We take trademark infringement seriously and are actively taking measures to address any instances of unauthorized use. This includes legal action against parties found to be infringing upon our intellectual property rights.

We urge our customers, partners, African representatives and the general public to remain vigilant and report any suspected instances of trademark infringement directly to us. Your cooperation in this matter is crucial in helping us protect our brand and preserve the integrity of our business.

As always, we remain dedicated to providing high quality medical solutions in the sub-Sahara region of Africa and maintaining the highest standards of integrity and professionalism.

Thank you for your continued support and trust in our company.

Dafra Pharma